Pimecrolimus (ASM981) protects mice from developing T cell induced IBD without systemic immunosuppression, in contrast to tacrolimus (FK506) or cyclosporin A (CyA)
Moore, Henrietta D., Tyldesley, Mike, Martland, Amy, Edjlalipour, Marzieh, Pfann, MartinaVolume:
124
Language:
english
Journal:
Gastroenterology
DOI:
10.1016/S0016-5085(03)82489-7
Date:
April, 2003
File:
PDF, 258 KB
english, 2003